4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-22-038480
Chief Executive Officer sold 21,275 shares at $0.70 ($14,893)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2022-06-16 | Sale | −21,275 | $0.70 | $14,893 | 3,955,619 | D |
| Open-market sales · 21,275 sh · avg $0.70 · $14,893 | |||||||
Loading xslF345X03/doc4.xml…